Sabuwar Gwajin Gaggawa don Maganin Ciwon Cutar Prostate

A KYAUTA Kyauta 2 | eTurboNews | eTN
Written by Linda Hohnholz

Hinova Pharmaceuticals Inc., wani kamfani na likitanci na asibiti wanda ya mai da hankali kan haɓaka sabbin hanyoyin kwantar da hankali don cututtukan daji da cututtukan rayuwa ta hanyar fasahohin lalata furotin da aka yi niyya, ya sanar da cewa an sami nasarar yin amfani da mara lafiya na farko da ke da cutar kansar prostate mai jurewa (mCRPC) a cikin wani lokaci na I. Gwajin gwaji na asibiti na HP518, mai zaɓin zaɓi sosai kuma na baka wanda ke rage ɓarna na ɓarna da ke niyya da mai karɓar androgen (AR). Binciken da ake ci gaba da buɗaɗɗen lakabin Mataki na I a Ostiraliya zai kimanta aminci, magunguna, da ayyukan rigakafin ƙari na HP518 a cikin marasa lafiya tare da mCRPC.

An gano HP518 kuma an haɓaka shi ta hanyar dandalin gano magunguna masu lalata furotin da aka yi niyya ta Hinova. Yana da yuwuwar shawo kan juriyar maganin ciwon daji na prostate saboda wasu takamaiman maye gurbi na AR.

Chimeric degraders ƙananan ƙwayoyin cuta ne masu aiki guda biyu waɗanda ke haɓaka lalata sunadaran da aka yi niyya tare da babban ƙarfi da zaɓi mai girma. Wannan fasaha tana da yuwuwar kai hari ga wuraren da ba za a iya yin amfani da su ba da kuma shawo kan matsalar juriyar magungunan na ƙananan ƙwayoyin ƙwayoyin cuta na gargajiya.

"Wannan wani muhimmin ci gaba ne a ci gaban kokarinmu tun daga gano magunguna zuwa binciken asibiti," in ji Yuanwei Chen, Ph.D., Shugaba da Shugaba na Hinova. "Mun yi farin ciki game da shi kuma mun sadaukar da kai don kawo sabbin zaɓuɓɓukan magani ga marasa lafiya a duk duniya!"

Ta hanyar dandalin gano magunguna masu lalata sunadaran da aka yi niyya, Hinova na iya tantance ayyukan lalata furotin cikin sauri da cim ma ƙira mai inganci da haɓaka masu ɓarna chimeric. Bugu da ƙari, Hinova yana da ƙwarewa mai zurfi a cikin sarrafa sarrafa sinadarai na mahadi na lalatawar Chimeric.

ABUBUWAN DA ZA KU GUDU DAGA WANNAN LABARI:

  • Ta hanyar dandalin gano magunguna masu lalata sunadaran da aka yi niyya, Hinova na iya tantance ayyukan lalata furotin cikin sauri da cim ma ƙira mai inganci da haɓaka masu lalata chimeric.
  • "Wannan wani muhimmin ci gaba ne a ci gaban kokarinmu daga gano magunguna zuwa binciken asibiti,".
  • Wannan fasaha tana da yuwuwar kai hari ga wuraren da ba za a iya amfani da su ba da kuma shawo kan matsalar juriyar magungunan na ƙananan ƙwayoyin ƙwayoyin cuta na gargajiya.

<

Game da marubucin

Linda Hohnholz

Edita a shugaba don eTurboNews bisa ga eTN HQ.

Labarai
Sanarwa na
bako
0 comments
Bayanin Cikin Lissafi
Duba duk maganganu
0
Za a son tunanin ku, don Allah sharhi.x
()
x
Share zuwa...